🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free →

Retatrutide

For In-Vitro Laboratory Research Use Only • Not for Human or Veterinary Use

Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide studied in GLP-1, GIP and glucagon receptor research. Supplied as lyophilised powder for in-vitro laboratory research. Select a vial option for current price and availability, and check its batch documentation before ordering.

For laboratory research use only, Not for human or veterinary use.

Check batch documentation · Read the Retatrutide UK buying guide

£63.99 – £165.99 / vialFrom £54.39 / vial (15% Multi-Vial Savings)

🧪 MULTI-VIAL RESEARCH SAVINGS Buy 2 Save 10% · Buy 3+ Save 15%
1 Vial Standard £63.99 / vial
Buy 2 Vials Save 10% £57.59 / vial
Buy 3+ Vials Save 15% £54.39 / vial
Mix & match vials — 10% off 2 vials and 15% off 3+ vials auto-applies in your basket + Free Tracked 24 on all pens · other orders free over £50, otherwise £5.99.
💧 Reconstitution Bundle: add 10ml Bacteriostatic Water (£5.99) with any lyophilised peptide — FREE on orders over £100.
💧 + Add 10ml BAC Water (£5.99 / Free £100+)
Ways to pay. You place the order first, then pay by a secure payment link (all major credit and debit cards including Visa, Mastercard and American Express, Apple Pay, Google Pay, PayPal including Pay in 3, or a Zilch virtual card) or by UK bank transfer.

FOR IN-VITRO LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

Retatrutide research peptide

Product at a glance

Detail Information
Research name Retatrutide
Development code LY3437943
Structure 39-amino-acid peptide with a fatty-acid side chain
Research focus GLP-1R, GIPR and glucagon receptor signalling
Supplied form Lyophilised powder in a sealed vial
Listed vial options 5, 10, 15, 20, 30, 40, 50 and 60 mg
Current availability See the size selector

Listed sizes are labelled material amounts, not application instructions. Availability varies by option. This page describes the vial product, not a different product format.

Batch documents: check the exact match

Use the COA and verification page to check the compound name, batch identifier, sample description, methods and results. A certificate documents its tested sample; it is not automatically evidence for every size or batch of the same compound.

The current page identifies certificates for 10, 20, 30, 40 and 60 mg batches. It says other options may display a certificate from another size. Treat such a document as reference material unless its relationship to the actual supplied batch is documented. Ask for clarification if your option has no matching certificate.

HPLC purity alone does not establish total peptide content, sterility or endotoxin status. Do not assume a test was performed unless it is recorded.

What receptor research examines

Retatrutide is described in the literature as a triple-receptor agonist. In a laboratory context, that means researchers examine interactions with GLP-1, GIP and glucagon receptors, using defined experimental systems and measured signalling readouts.

Receptor expression, assay design and the material tested all affect interpretation. A result from a published study is not a performance guarantee for a research vial. This page makes no clinical or personal-use claims.

Read the Learning Hub for guidance on interpreting evidence, or watch the Retatrutide research explainer.

Laboratory storage and records

Follow the batch documentation and your laboratory’s approved procedures. Keep containers sealed and protected from moisture and light, and record receipt and batch details. The Learning Hub explains general storage principles; it does not replace batch-specific documentation. No preparation protocol or application quantity is supplied here.

Frequently asked questions

What does LY3437943 mean?
It is the development code associated with Retatrutide in the research literature.

What does “triple-receptor” mean here?
It refers to research involving GLP-1, GIP and glucagon receptors. It does not describe a guaranteed experimental outcome.

Can I use another size’s COA to verify my vial?
Not automatically. Verify the batch relationship first. The same compound name alone does not establish that the supplied material was the tested sample.

Where do I find current price and delivery details?
Use the product selector and checkout. The UK buying guide provides supporting purchasing and documentation context.

Research use notice

For laboratory research use only, Not for human or veterinary use. Supplied as a research chemical, not as a medicine, food or supplement. Information is for research documentation and does not provide application instructions.

Research you can verify.

Related reading

References

  1. Li W, et al. Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide. Cell Discov. 2024. PubMed 39019866
  2. Neumann J, et al. Contractile effects of retatrutide in isolated mouse atrial preparations. Naunyn Schmiedebergs Arch Pharmacol. 2025. PubMed 40464942
  3. Tong LH, et al. Development and validation of a multiplexed LC-HRMS method for nine GLP-1 receptor agonists and its pharmaceutical application. J Chromatogr A. 2026. PubMed 42603384

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Cover of the free guide: How to read a COA

Free guide

How to read a COA

Get it by email, plus our research updates. No spam, unsubscribe any time.

We will email you to confirm first, then send the guide. We use your name and email only to send you these emails. Privacy policy. For laboratory research use only.

Listed on PepmarketVerified on PeptideReview
🎬 Scientific Explainer Video · What It Is For & How It Works

Retatrutide — Laboratory Mechanism & Research Overview

⬇ Download Video (MP4) All Peptide Videos →
🔬 What Is This Peptide Researched For?
  • Investigating simultaneous activation of human GLP-1R, GIPR & GCGR in metabolic models
  • Comparing multi-receptor incretin + glucagon energy-expenditure signalling vs single agonists
  • Studying hepatic lipid oxidation, glycaemic homeostasis & adipose thermogenesis pathways
⚙️ How Does It Work? (Mechanism of Action)
1. Triple Receptor Binding: Binds GLP-1R, GIPR and Glucagon (GCGR) G-protein-coupled receptors on target cells.
2. Gs / Adenylyl Cyclase Cascade: Elevates intracellular cAMP, activating PKA and EPAC2 second-messenger pathways.
3. Cellular Metabolic Readout: Coordinates insulinotropic signalling, lipolysis & hepatic fatty-acid oxidation in vitro.
📚 Peer-Reviewed Literature · PubMed Indexed

Published Research — Retatrutide (LY3437943)

NCBI PubMed Database ↗ Verify Batch COAs →
  1. [1] Li W et al. · Cell Discov (2024)

    Cryo-EM structural determination of retatrutide bound to GLP-1R, GIPR, and GCGR in complex with heterotrimeric Gs proteins, mapping the N-terminal transmembrane recognition contacts underlying triple Class B1 GPCR agonism.

    PMID: 39019866 ↗ DOI: 10.1038/s41421-024-00700-0 ↗
  2. [2] Neumann J et al. · Naunyn Schmiedebergs Arch Pharmacol (2025)

    Ex-vivo pharmacological assay in isolated murine atrial preparations characterizing GCGR-, GIPR-, and GLP-1R-coupled adenylyl cyclase, intracellular cAMP, and protein kinase A (PKA) signalling pathways.

    PMID: 40464942 ↗ DOI: 10.1007/s00210-025-04335-0 ↗
  3. [3] Ma J et al. · Endocrine (2025)

    Pre-clinical murine assay examining renal pro-inflammatory cytokine (TNF-α, caspase-1, NLRP3) and pro-fibrotic marker (fibronectin, α-SMA, collagen I) gene expression alongside serum lipid and butyrate profiles.

    PMID: 39212900 ↗ DOI: 10.1007/s12020-024-03998-8 ↗
  4. [4] Tong LH et al. · J Chromatogr A (2026)

    Analytical validation of a C18 reversed-phase liquid chromatography–high-resolution mass spectrometry (LC-HRMS) method resolving single, dual, and triple receptor agonist peptides with sub-ppm mass accuracy and MS/MS fragment confirmation.

    PMID: 42603384 ↗ DOI: 10.1016/j.chroma.2026.467288 ↗

References are provided for scientific context only. All Corex Vitality™ compounds are supplied strictly for in-vitro laboratory research use (RUO).